Karen LaRochelle has served on our board of directors since June 2020.  Ms. LaRochelle presently holds multiple industry roles as Senior Vice President of Corporate and Business Development for WindMIL Therapeutics Inc., Chief Business Officer for Artax Biopharma Inc., and Venture Partner for Advent Life Sciences LLP.  

Ms. LaRochelle’s career has focused on strategy and collaborations for pharmaceutical and biotechnology companies in the US, Europe and China including strategic collaborations, M&A and out-licensing.  From 2016 to 2019, Ms. LaRochelle served as the Chief Business Officer of PsiOxus Therapeutics and from 2013-2016 served as the Principal of LaRochelle Advisors, LLC providing strategy and collaboration services to multiple biotechnology companies. From 1993-2013, Ms. LaRochelle spent the first twenty years of her career with Bristol-Myers Squibb (NYSE: BMY) including as Global Head of Negotiations and as Head of Business Development in China, following earlier positions in alliance management, strategy, analysis and finance.

Ms. LaRochelle received her Master of Business Administration from Columbia University and a Bachelor of Science in Industrial Engineering from Lehigh University. She currently serves on the Advisory Board for the Lehigh University P.C. Rossin College of Engineering.